PAVmed Subsidiary Lucid Diagnostics Launches World-Class Medical Advisory Board and Appoints Chief Medical Officer Feb 28, 2019 12:49pm EST
PAVmed Subsidiary Lucid Diagnostics Files 510(k) Submission with FDA for EsoCheck™ Cell Collection Device Nov 29, 2018 7:30am EST
PAVmed Reports Third Quarter 2018 Financial Results and Provides Business Update Nov 15, 2018 7:30am EST
PAVmed to Present at Dawson James Securities 4th Annual Small Cap Growth Conference Oct 23, 2018 7:30am EDT
PAVmed Reports Second Quarter 2018 Financial Results and Provides Business Update Aug 14, 2018 7:30am EDT
PAVmed Inc. to Hold SECOND QUARTER FINANCIAL RESULTS AND BUSINESS UPDATE Conference Call on August 22, 2018 Aug 09, 2018 7:30am EDT
